In the T241 fibrosarcoma model, increased surface expression of CD86 on cDCs was observed in the tumor draining lymph nodes of mice treated with anti-CD40 mAb alone and in mice treated with anti-CD40 mAb in combination with sunitinib (Figure 2B). The gene discussed is CD40; the disease is neoplasm.